- About CTTC
- Invention Disclosure
- News & Events
Targeting Notch 3 Receptor Function Using Specific Peptides and Antipeptide Biomolecules
The present invention involves the use of peptides from Notch3, and antibodies that recognize epitopes represented by those peptides, as anti-cancer agents. Methods of combination therapy using standard anti-cancer protocols in conjunction with Notch3 peptides and antibodies also are provided.
Inventors:Thao DangDavid CarboneRaymond MernaughDavid Blum